Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival
Authors:
Open Access
- 7 March 2024
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 7 (2) , 248-257
Abstract
No abstract availableKeywords
Funding Information
- NIH
- Cancer Research UK
This publication has 42 references indexed in Scilit:
- Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate CancerJAMA Oncology, 2023
- Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate CancerEuropean Urology Open Science, 2023
- Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesisThe Journal of Pathology, 2021
- Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in PolandInternational Journal of Cancer, 2020
- Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic PanelEuropean Urology, 2019
- A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancerThe Prostate, 2018
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathEuropean Urology, 2017
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason ScoreEuropean Urology, 2016
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerEuropean Urology, 2015
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)Human Genetics, 2012